VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by Sonny7on Jan 23, 2014 10:55pm

197 Views

Post# 22128224

RE:RE:RE:RE:RE:Ventripoint Announces 510(k) Submission for VMS Heart Analys

Hey Euanus. Why don't you drown in your own misery all by yourself without using this board as a vehicle to display your sour negative attitude. Just to show you how much you don't know, I'll make a prediction that it takes less than 30 working days to see us have news that this gets approval. Trial facts have shown that this is not a failure so where is your perceived problem? Go play VLT's

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks